Allergan Buys Global Rights To Serenity's Phase III Drug For Frequent Nighttime Urination
Allergan also will have right of first refusal for Ser-120 in pediatric bedwetting, though this use is in early stage development.
Allergan also will have right of first refusal for Ser-120 in pediatric bedwetting, though this use is in early stage development.